https://outcomes4me.com/cancer-hubs/asco-briefing-room-ovarian-cancer/5-ovarian-cancer-studies-patients-should-be-paying-attention-to-at-asco-2026/ 2026-06-08T13:50:27+00:00 https://outcomes4me.com/wp-content/uploads/2026/06/GettyImages-2222797818-2.jpg https://outcomes4me.com/cancer-hubs/asco-briefing-room-ovarian-cancer/real-world-research-validates-mirasol-trial-results-for-ovarian-cancer-patients/ 2026-06-08T14:47:41+00:00 https://outcomes4me.com/wp-content/uploads/2026/06/GettyImages-1343874702.jpg https://outcomes4me.com/cancer-hubs/asco-briefing-room-ovarian-cancer/new-research-reassures-patients-about-the-safety-of-mirvetuximab-soravtansine-in-ovarian-cancer/ 2026-06-08T14:48:16+00:00 https://outcomes4me.com/wp-content/uploads/2026/06/GettyImages-2261481178.jpg https://outcomes4me.com/cancer-hubs/asco-briefing-room-ovarian-cancer/extending-survival-in-platinum-resistant-ovarian-cancer-inside-the-rosella-trial/ 2026-06-08T14:48:38+00:00 https://outcomes4me.com/wp-content/uploads/2026/06/GettyImages-1387450780.jpg https://outcomes4me.com/cancer-hubs/asco-briefing-room-ovarian-cancer/gentle-yoga-as-an-important-tool-for-cancer-survivors/ 2026-06-08T14:48:59+00:00 https://outcomes4me.com/wp-content/uploads/2026/06/exercise-new-research.jpg https://outcomes4me.com/cancer-hubs/asco-briefing-room-ovarian-cancer/new-chemo-free-combo-shows-early-promise-in-hard-to-treat-ovarian-cancer/ 2026-06-08T14:49:14+00:00 https://outcomes4me.com/wp-content/uploads/2026/06/asco-ovarian-chemo-free.jpg https://outcomes4me.com/cancer-hubs/asco-briefing-room-ovarian-cancer/could-a-one-time-therapy-change-treatment-for-advanced-ovarian-cancer/ 2026-06-08T14:49:28+00:00 https://outcomes4me.com/wp-content/uploads/2026/06/Dr-Jessica-Lin-biomarker-testing-recap-1-.jpg https://outcomes4me.com/cancer-hubs/asco-briefing-room-ovarian-cancer/advances-in-platinum-resistant-ovarian-cancer-chipro-trial-combo-therapy-results/ 2026-06-08T14:49:50+00:00 https://outcomes4me.com/wp-content/uploads/2026/06/ctDNA-2.jpg https://outcomes4me.com/cancer-hubs/asco-briefing-room-ovarian-cancer/napistar-1-01-trial-results-tub-040-shows-61-response-rate-in-ovarian-cancer/ 2026-06-08T14:50:23+00:00 https://outcomes4me.com/wp-content/uploads/2026/06/GettyImages-2261530779-1.jpg https://outcomes4me.com/cancer-hubs/asco-briefing-room-ovarian-cancer/short-term-fasting-during-chemo-encouraging-early-findings-for-ovarian-cancer-patients/ 2026-06-08T14:51:16+00:00 https://outcomes4me.com/wp-content/uploads/2026/06/GettyImages-2278923149.jpg https://outcomes4me.com/cancer-hubs/asco-briefing-room-ovarian-cancer/nhs-galleri-trial-data-reveals-significant-reduction-in-late-stage-diagnoses/ 2026-06-08T16:51:17+00:00 https://outcomes4me.com/wp-content/uploads/2026/06/clinical-trials-day.jpg